0 By In Neurodegenerative diseases, PublicationsPosted 28. December 2019sTREM2, a potential biomarker in ADsTREM2 correlates with microglia activation, and higher CSF sTREM2 levels can be linked to reduced cognitive decline and slower rates of Plaque accumulation in AD patients. READ MORE
